017 - "Feet First" with Ahmed Zobi

Let's Combinate · 26 Jan 2022 · 1h 07m

What this episode covers

Ahmed Zobi, Founder and CEO of Syntr Health Technologies, explains how he bootstrapped his company from a university project to FDA 510(k) clearance for the SyntrFuge System, a device that automates the microsizing of adipose tissue for body contouring and wound care. Zobi details the strategic decision to target aesthetics and orthopedics first to generate revenue while pursuing diabetic foot ulcer indications, and describes the intense personal sacrifices made during the grant submission process and the COVID-19 pandemic. He emphasizes the importance of leveraging mentors, conducting customer discovery through the NSF iCorps program, and building a robust quality management system early to navigate regulatory requirements.

Other shows on the same ground, closest first.

  • Global Medical Device Podcast · 43m

    #381: MedTech Advice from an Accidental Entrepreneur

    Dr. Asha Parekh, CEO and co-founder of Frontline Medical Technologies, explains how she transitioned from a biomedical engineering PhD to an accidental entrepreneur with vascular surgeon Dr. Adam Power. They developed the COBRA-OS, a bleeding control device used in trauma care, military settings, and Formula One race tracks. Parekh discusses the critical role of passion in overcoming challenges, the art of pitching to secure millions in funding, and the importance of founders remaining the ultimate experts on their device's regulatory pathway rather than relying blindly on consultants.

  • Global Medical Device Podcast · 42m

    #336: From Academia to FDA Clearance (True Quality Roadshow - Boston)

    Christy Sheehy-Bensinger, CEO and Founder of C-Light Technologies, discusses her journey from optical engineering at Corning and a PhD at UC Berkeley to securing FDA clearance for the RediTrack eye movement monitor. She details the strategic pivot from seeking digital health investors to focusing on medical device investors, the critical role of NIH grants in validating the technology, and the importance of building a quality culture early using Greenlight Guru. She also shares insights on selecting predicate devices for 510(k) clearance and the ongoing challenges of post-clearance commercialization and team scaling.

  • Global Medical Device Podcast · 21m

    Sara Naab On Going From Idea to Funding to One of the Bay Area's Most Innovative Life Sciences Co's

    Sara Naab, co-founder and director of quality and marketing at Sandstone Diagnostics, discusses the journey of building Trak, an over-the-counter male fertility monitoring system comprising a mini centrifuge and companion app. She highlights manufacturing, regulatory hurdles with the FDA, and investor relations as the primary challenges, contrasting them with the relative ease of their design control and quality systems. Naab explains how the company leverages agile software methodologies and a culture of humor to navigate the sensitive nature of sperm testing and achieve recognition as one of the Bay Area's most innovative life sciences companies.

  • Global Medical Device Podcast · 39m

    #455: MedTech Founder 101: Shifting from Corporate to Startup with John Schindler

    John Schindler, CEO of Liquet Medical, discusses the transition from corporate roles at Atrium and Merit Medical to founding a startup, emphasizing the 'novel but simple' philosophy for vascular drug delivery devices. He explains how Liquet leverages its 510(k) clearance for pulmonary embolism treatment while planning an IDE trial, advocating for limited market releases to build strategic enterprise value through intentional clinical data. Schindler also covers the challenges of fundraising, negotiating with regulatory service providers, and the importance of early FDA engagement to avoid timeline resets.

  • Global Medical Device Podcast · 45m

    From Startup to Industry Leader: LIVE RECORDING AT SCBIO CONFERENCE

    Shawn Regan, CEO and Co-founder of Rhythmlink International, discusses the company's 20-year journey from a bootstrapped garage startup to an industry leader in neurophysiologic monitoring devices. He details the strategic decision to pivot from reusable to disposable electrodes, the critical collaboration with the FDA to achieve the first MRI-cleared products, and the operational challenges of manufacturing in China. Regan also explains the recent decision to maintain MDD certification in the EU rather than transitioning to the more burdensome MDR, and how the company leverages its in-house capabilities for OEM partnerships with firms like Johnson & Johnson and Stryker.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Let's Combinate. The episode itself belongs to its publisher.